Currency in USD
| Earnings Estimate | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|
| No. of Analysts | 4 | 2 | 4 | 5 |
| Avg. Estimate | -0.02 | -0.03 | -0.05 | 0.07 |
| Low Estimate | -0.04 | -0.09 | -0.08 | -0.25 |
| High Estimate | 0 | 0.02 | -0.04 | 0.28 |
| Year Ago EPS | 0.34 | 0.03 | 0.06 | -0.05 |
| Revenue Estimate | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|
| No. of Analysts | 6 | 3 | 6 | 6 |
| Avg. Estimate | 26.76M | 27.63M | 113.84M | 114.02M |
| Low Estimate | 24M | 27M | 111M | 102.2M |
| High Estimate | 31.45M | 28.5M | 118.54M | 124.6M |
| Year Ago Sales | 28.63M | 29.35M | 108.1M | 113.84M |
| Sales Growth (year/est) | -6.50% | -5.90% | 5.30% | 0.20% |
| Earnings History | 2023-03-30 | 2023-06-29 | 2023-09-29 | 2023-12-30 |
|---|
| EPS Est. | -0.05 | -0.01 | 0.02 | 0.03 |
| EPS Actual | 0.34 | 0.03 | -0.05 | -0.02 |
| Difference | 0.39 | 0.04 | -0.07 | -0.05 |
| Surprise % | 780.00% | 400.00% | -350.00% | -166.70% |
| EPS Trend | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|
| Current Estimate | -0.02 | -0.03 | -0.05 | 0.07 |
| 7 Days Ago | -0.02 | -0.03 | -0.05 | 0.07 |
| 30 Days Ago | -0.02 | -0.03 | -0.06 | 0.05 |
| 60 Days Ago | -0.02 | -0.03 | -0.06 | 0.05 |
| 90 Days Ago | 0.04 | 0 | 0.02 | 0.32 |
| EPS Revisions | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|
| Up Last 7 Days | N/A | N/A | N/A | N/A |
| Up Last 30 Days | N/A | N/A | N/A | N/A |
| Down Last 7 Days | N/A | N/A | N/A | N/A |
| Down Last 30 Days | N/A | N/A | N/A | N/A |
| Growth Estimates | MEDXF | Industry | Sector(s) | S&P 500 |
|---|
| Current Qtr. | -105.90% | N/A | N/A | N/A |
| Next Qtr. | -200.00% | N/A | N/A | N/A |
| Current Year | -183.30% | N/A | N/A | N/A |
| Next Year | 240.00% | N/A | N/A | N/A |
| Next 5 Years (per annum) | N/A | N/A | N/A | N/A |
| Past 5 Years (per annum) | N/A | N/A | N/A | N/A |
